MARKER FOR DIAGNOSING HER2 INHIBITOR RESISTANCE CANCER, DIAGNOSTIC KIT COMPRISING THE SAME AND METHOD FOR DIAGNOSING HER2 INHIBITOR RESISTANCE CANCER

摘要

The present invention relates to a composition for detecting an marker for diagnosing HER2 inhibitor resistant cancer, a diagnostic kit comprising the same, and a method for detecting the marker and, more specifically, to a composition for detecting a marker for diagnosing HER2 inhibitor resistant cancer, which can easily determine resistance of an HER2-positive cancer patient to a HER2 inhibitor conventionally prescribed to the HER2 with high reliability, to a diagnostic kit comprising the same, and to a method for detecting the marker.